Hemolysis-free blood plasma separation

US10596522B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10596522-B2
Application numberUS-201615567919-A
CountryUS
Kind codeB2
Filing dateApr 25, 2016
Priority dateApr 24, 2015
Publication dateMar 24, 2020
Grant dateMar 24, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A simple and robust on-chip blood plasma separation device is provided. The device is configured to integrate with downstream detection modules and provides sample-to-answer microfluidic POC diagnostics devices.

First claim

Opening claim text (preview).

What is claimed is: 1. A microfluidic device for separating cellular components from plasma of a whole blood sample, said device comprising: a microfluidic component comprising: a sample inlet configured to receive said blood sample; a filter configured for said separating; a filtration chamber configured to retain said filter on an upper surface of said filtration chamber; and a microfluidic channel through which said sample inlet and said filtration chamber fluidically communicate wherein the microfluidic channel is disposed in a lower portion of each of said sample inlet and said filtration chamber. 2. The microfluidic device according to claim 1 , wherein said filtration chamber is configured as a vertical upflow filtration chamber. 3. The microfluidic device according to claim 2 , wherein said microfluidic component is configured such that said sample passes from said lower portion of said sample inlet to said lower portion of said filtration chamber through said microfluidic channel and rises to an upper portion of said filtration chamber, contacts said filter, said plasma transversing said filter, thereby separating said cellular components from said plasma. 4. The microfluidic device according to claim 1 , wherein said microfluidic component is fabricated from an upper subunit and a lower subunit, wherein said upper subunit and said lower subunit are mated subunits and bonded together. 5. The microfluidic device according to claim 4 , wherein said lower subunit comprises a first depression and a second depression, each formed in an upper surface thereof, such that when said upper subunit and said lower subunit are mated, said first depression fluidically communicates with said lower portion of said sample inlet and said second depression fluidically communicates with said lower portion of said filtration chamber, and wherein said first depression and said second depression fluidically communicate with each other via the microfluidic channel, thereby bringing in to fluidic communication said sample inlet and said filtration chamber. 6. The microfluidic device according to claim 4 , wherein said upper subunit comprises a first port for said sample inlet and a first port for said filtration chamber, each communicating with an upper surface of said upper subunit. 7. The microfluidic device according to claim 6 , wherein said sample inlet comprises a second port and said filtration chamber comprises a second port, wherein each said second port is in a lower surface of said upper subunit. 8. The microfluidic device according to claim 6 , wherein said upper subunit further comprises a post-filtration void, which is a member selected from a post-filtration microfluidic channel and a collection chamber and a combination thereof, wherein said void is in fluidic communication with an outlet for said filtration chamber. 9. The microfluidic device according to claim 8 , wherein said post-filtration void is a post-filtration microfluidic channel, and wherein said post-filtration microfluidic channel is configured as a serpentine channel. 10. The microfluidic channel according to claim 8 , wherein said post-filtration void is a post-filtration microfluidic channel, and wherein said upper surface of said upper subunit further comprises markings corresponding to volume adjacent said post-filtration microfluidic channel. 11. The microfluidic device according to claim 8 , wherein said post-filtration void is a collection chamber, and wherein said collection chamber further comprises a port fluidically communicating therewith through which a filtered component of said sample can be withdrawn or one or more substances can be injected, thereby contacting said filtered component of said sample. 12. The microfluidic device according to claim 6 , wherein said upper or lower subunit further comprises a suction chamber configured to maintain an ambient atmosphere of less than about 1 Atm. 13. The microfluidic device according to claim 12 , wherein said suction chamber is in direct or indirect fluidic communication with said filtration chamber. 14. The microfluidic device according to claim 1 , wherein a lower surface of said microfluidic component is bonded to a substrate. 15. The microfluidic device according to claim 1 , wherein an upper surface of said microfluidic component is bonded to a cover, wherein said cover comprises a through hole port aligned with said sample inlet port. 16. The microfluidic device according to claim 1 , wherein said microfluidic component is fabricated from a polymer. 17. The microfluidic device according to claim 16 , wherein said polymer is polydimethylsiloxane. 18. The microfluidic device according to claim 1 , wherein said cellular components are red blood cells, white blood cells, or platelets. 19. A method of separating plasma from red blood cells in a whole blood sample using the device according to claim 1 , said method comprising: (a) adding said whole blood sample to said sample inlet through a sample inlet port; (b)transferring said whole blood sample from said sample inlet to said filtration chamber through said microfluidic channel communicating with said sample inlet and said filtration chamber, such that said sample flows vertically from the lower portion of said filtration chamber to an upper portion of said filtration chamber and contacts said filter; (c) transferring a liquid component of said whole blood sample through said filter and retaining within said filtration chamber a solid component of said whole blood sample, wherein said separating, is performed under conditions selected such that said solid component of said whole blood sample does not adhere to said filter and drops in to said filtration chamber. 20. The method according to claim 19 , wherein said device is evacuated such that pressure within said device is less than about 1 Atm. 21. The method according to claim 19 , wherein said separating is completed to a selected level without application of external vacuum to said device during said separating.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10596522B2 cover?
A simple and robust on-chip blood plasma separation device is provided. The device is configured to integrate with downstream detection modules and provides sample-to-answer microfluidic POC diagnostics devices.
Who is the assignee on this patent?
Univ California
What technology area does this patent fall under?
Primary CPC classification B01D63/088. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).